Post-anastomotic venous stenosis after Optiflow deployment: An unexpected outcome
Arteriovenous fistula failure represents a major cause of hospitalization and a significant economic burden for end-stage renal disease patients on hemodialysis. The Optiflow (Bioconnect Systems Inc., Ambler, PA) is a new device developed to improve arteriovenous fistula outcomes and decrease failur...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-05-01
|
Series: | SAGE Open Medical Case Reports |
Online Access: | https://doi.org/10.1177/2050313X19851002 |
id |
doaj-e08709b650d245dcb9b7935214986bf4 |
---|---|
record_format |
Article |
spelling |
doaj-e08709b650d245dcb9b7935214986bf42020-11-25T02:34:26ZengSAGE PublishingSAGE Open Medical Case Reports2050-313X2019-05-01710.1177/2050313X19851002Post-anastomotic venous stenosis after Optiflow deployment: An unexpected outcomeZiad Al Adas0George Haddad1Bhavin C Patel2Lalathaksha Kumbar3Baha Al-Abid4Praveen Balraj5Loay S Kabbani6Department of Vascular Surgery, Henry Ford Hospital, Detroit, MI, USADepartment of Vascular Surgery, Henry Ford Hospital, Detroit, MI, USADepartment of Nephrology, Henry Ford Hospital, Detroit, MI, USADepartment of Nephrology, Henry Ford Hospital, Detroit, MI, USADepartment of Nephrology, Henry Ford Hospital, Detroit, MI, USADepartment of Vascular Surgery, Henry Ford Hospital, Detroit, MI, USADepartment of Vascular Surgery, Henry Ford Hospital, Detroit, MI, USAArteriovenous fistula failure represents a major cause of hospitalization and a significant economic burden for end-stage renal disease patients on hemodialysis. The Optiflow (Bioconnect Systems Inc., Ambler, PA) is a new device developed to improve arteriovenous fistula outcomes and decrease failure rates by reducing the risk of stenosis and improving maturation rates. This case report describes a 50-year-old male with hypertensive nephropathy on dialysis who had multiple arteriovenous fistula failures in the past. He was scheduled to undergo brachiocephalic fistula construction using the Optiflow device. After 8 months of use, the new fistula developed a peri-anastomotic venous stenosis, just distal to the Optiflow device. To our knowledge, this is the first time such a complication has been reported.https://doi.org/10.1177/2050313X19851002 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ziad Al Adas George Haddad Bhavin C Patel Lalathaksha Kumbar Baha Al-Abid Praveen Balraj Loay S Kabbani |
spellingShingle |
Ziad Al Adas George Haddad Bhavin C Patel Lalathaksha Kumbar Baha Al-Abid Praveen Balraj Loay S Kabbani Post-anastomotic venous stenosis after Optiflow deployment: An unexpected outcome SAGE Open Medical Case Reports |
author_facet |
Ziad Al Adas George Haddad Bhavin C Patel Lalathaksha Kumbar Baha Al-Abid Praveen Balraj Loay S Kabbani |
author_sort |
Ziad Al Adas |
title |
Post-anastomotic venous stenosis after Optiflow deployment: An unexpected outcome |
title_short |
Post-anastomotic venous stenosis after Optiflow deployment: An unexpected outcome |
title_full |
Post-anastomotic venous stenosis after Optiflow deployment: An unexpected outcome |
title_fullStr |
Post-anastomotic venous stenosis after Optiflow deployment: An unexpected outcome |
title_full_unstemmed |
Post-anastomotic venous stenosis after Optiflow deployment: An unexpected outcome |
title_sort |
post-anastomotic venous stenosis after optiflow deployment: an unexpected outcome |
publisher |
SAGE Publishing |
series |
SAGE Open Medical Case Reports |
issn |
2050-313X |
publishDate |
2019-05-01 |
description |
Arteriovenous fistula failure represents a major cause of hospitalization and a significant economic burden for end-stage renal disease patients on hemodialysis. The Optiflow (Bioconnect Systems Inc., Ambler, PA) is a new device developed to improve arteriovenous fistula outcomes and decrease failure rates by reducing the risk of stenosis and improving maturation rates. This case report describes a 50-year-old male with hypertensive nephropathy on dialysis who had multiple arteriovenous fistula failures in the past. He was scheduled to undergo brachiocephalic fistula construction using the Optiflow device. After 8 months of use, the new fistula developed a peri-anastomotic venous stenosis, just distal to the Optiflow device. To our knowledge, this is the first time such a complication has been reported. |
url |
https://doi.org/10.1177/2050313X19851002 |
work_keys_str_mv |
AT ziadaladas postanastomoticvenousstenosisafteroptiflowdeploymentanunexpectedoutcome AT georgehaddad postanastomoticvenousstenosisafteroptiflowdeploymentanunexpectedoutcome AT bhavincpatel postanastomoticvenousstenosisafteroptiflowdeploymentanunexpectedoutcome AT lalathakshakumbar postanastomoticvenousstenosisafteroptiflowdeploymentanunexpectedoutcome AT bahaalabid postanastomoticvenousstenosisafteroptiflowdeploymentanunexpectedoutcome AT praveenbalraj postanastomoticvenousstenosisafteroptiflowdeploymentanunexpectedoutcome AT loayskabbani postanastomoticvenousstenosisafteroptiflowdeploymentanunexpectedoutcome |
_version_ |
1724808933270355968 |